Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma
Authors:
Open Access
- 14 June 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (30) , 47794-47807
Abstract
Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinomaKeywords
This publication has 40 references indexed in Scilit:
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up studyThe Lancet, 2013
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic FactorsAmerican Journal of Gastroenterology, 2012
- KASL Clinical Practice Guidelines: Management of chronic hepatitis BClinical and Molecular Hepatology, 2012
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- The Minimal Ablative Margin of Radiofrequency Ablation of Hepatocellular Carcinoma (> 2 and < 5 cm) Needed to Prevent Local Tumor Progression: 3D Quantitative Assessment Using CT Image FusionAmerican Journal of Roentgenology, 2010
- Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis #Hepatology, 2009
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateHepatology International, 2008
- Chronic hepatitis BHepatology, 2007
- Diagnosis of Small Hepatocellular Carcinoma * #Hepatology, 2005